Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc.

生物技术研究

Boston,MA 10,136 位关注者

The era of genetic neuroscience has arrived

关于我们

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis is applying insights into the genetic mutations that drive excitation-inhibition imbalance in diseases to select biological targets for rare and more prevalent neurological disorders. We share a common vision of reshaping the human condition into a more freeing and fulfilled existence by developing high impact medicines for patients and families affected by and living with complex brain disorders. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum?, and antisense oligonucleotide (ASO) platform, Solidus?, using our understanding of shared biological targets and circuits in the brain.

网站
https://www.praxismedicines.com
所属行业
生物技术研究
规模
51-200 人
总部
Boston,MA
类型
上市公司

地点

  • 主要

    99 High Street

    30th Floor

    US,MA,Boston,02110

    获取路线

Praxis Precision Medicines, Inc.员工

动态

相似主页

查看职位

融资